Home › Products › Oncology › Tegoyes 20mg Capsule
Tegoyes 20mg Capsule
Salt Composition: TEGAFUR,GIMERACIL,OTERACIL
- Manufacturer: TORRENT PHARMACEUTICALS LTD
- Pack Size: 7 CAPSULE(s) IN A STRIP
- Dosage Form: CAPSULE
- Strength: 20MG+5.8MG+15.8MG
- Prescription Required
- Storage: Store in a refrigerator between 20°C to 25°C (68°F to 77°F). Keep away from moisture, heat, and light. It should not be frozen. Keep it in its original packaging until it is ready to be used. Keep out of the reach of children and pets.
₹1875.00₹3064.00
Inclusive of all taxes
Product Introduction
Tegoyes 20mg Capsule is a combination chemotherapy medication containing Tegafur, Gimeracil, and Oteracil. This S-1 regimen is indicated for gastric cancer, colorectal cancer, breast cancer, and pancreatic cancer. The capsule may be administered as monotherapy or in combination with other anticancer drugs. It is not recommended for patients under 18 years of age.
Inform your doctor if you have severe blood disorders, kidney disorders, or viral infections. Patients with dihydropyrimidine dehydrogenase (DPD) deficiency require particular attention before initiating treatment. Tegoyes 20mg Capsule contains lactose; patients with sugar intolerance must notify their physician prior to use.
Effective contraceptive measures should be used during therapy and for at least 6 months after the final dose.
Uses
Tegoyes 20mg Capsule is used in the treatment of Gastric cancer Colorectal cancer Breast cancer Pancreatic cancer
How it works
Tegoyes 20mg Capsules inhibit the growth and division of cancer cells, improve the effectiveness of the treatment, and reduce the risk of side effects, thereby providing therapeutic benefits to cancer patients.
How to Use
Tegoyes 20mg Capsules are typically taken orally, with or without food. The Capsule should be swallowed whole, not crushed, chewed, or broken. The recommended dosage can vary depending on the type of cancer being treated and other factors such as your overall health and response to treatment. Do not take a double dose to make up for a missed dose.
Side Effects
Like all medications, Tegoyes 20mg Capsules cause some side effects, although not everyone will experience them. Serious: Infection (fever, chills, sore throat, cough, flu-like symptoms) Bleeding or bruising (nosebleeds, bleeding gums) Shortness of breath or difficulty breathing Chest pain Irregular heartbeat Seizures Allergic reaction (swelling of the face, tongue, or throat; difficulty breathing) Liver problems (yellowing of the skin or eyes, dark urine, abdominal pain) Kidney problems (changes in urine output, swelling of the hands or feet) Common: Nausea Vomiting Diarrhea Loss of appetite Fatigue Mouth sores Skin rash Changes in taste Abdominal pain Constipation Headache
Expert Tips
If you have been prescribed Tegoyes 20mg Capsule, it is important to carefully read and understand the warnings and precautions associated with the medication. It increases the risk of infection, so patients should avoid close contact with infected persons. If you have an intolerance to sugars, you need to inform the physician. Avoid consumption of grapefruit during treatment. Use effective contraceptive measures during the therapy and for at least 6 after the last dose. Patients with diabetes require close monitoring during treatment. Always maintain a healthy and balanced diet to support your overall health and well-being.
References
- Nordic Group BV, European Medicines Agency, [Revised on 19/11/2020], [Accessed on 06/05/2023], https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf
- Masao Kobayakawa, Yasushi Kojima; Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies; OncoTargets and Therapy; [Published on 2011]; [Accessed on 06/05/2023]; https://pubmed.ncbi.nlm.nih.gov/22162925/
- Mahlberg R et al; New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin; Chemotherapy; [Published on 2017]; [Accessed on 06/05/2023]; https://www.karger.com/Article/Abstract/443984
Safety Advice
Pregnancy: unsafe Tegoyes 20mg Capsule is unsafe during pregnancy. It can harm the developing fetus, so pregnancy should be avoided while taking this medicine.
Lungs: Consult your doctor If you have a lung disease or lung cancer and are considering treatment with Tegoyes 20mg Capsule, it is important to discuss this medication's potential benefits and risks with your healthcare provider.
Breastfeeding: Consult your doctor It is unknown whether Tegoyes 20mg Capsules are excreted into human breast milk, so breastfeeding women should consult a doctor before taking it.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.